E Fund Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$783K Buy
+12,904
New +$752K 0.02% 206
2025
Q2
$482K Buy
10,409
+267
+3% +$13.1K 0.02% 234
2025
Q1
$619K Sell
10,142
-669
-6% -$39K 0.03% 206
2024
Q4
$611K Buy
10,811
+4,100
+61% +$229K 0.03% 196
2024
Q3
$347K Sell
6,711
-479
-7% -$22.5K 0.02% 237
2024
Q2
$299K Buy
7,190
+840
+13% +$37.6K 0.02% 232
2024
Q1
$344K Buy
6,350
+731
+13% +$37.2K 0.02% 256
2023
Q4
$288K Buy
5,619
+902
+19% +$47.3K 0.02% 235
2023
Q3
$274K Sell
4,717
-236
-5% -$14.5K 0.02% 219
2023
Q2
$317K Sell
4,953
-471
-9% -$31.6K 0.03% 210
2023
Q1
$376K Sell
5,424
-41
-0.8% -$2.89K 0.03% 187
2022
Q4
$393K Sell
5,465
-717
-12% -$54.1K 0.03% 184
2022
Q3
$439K Buy
6,182
+637
+11% +$46.2K 0.04% 158
2022
Q2
$427K Sell
5,545
-346
-6% -$26.4K 0.04% 176
2022
Q1
$430K Sell
5,891
-1,195
-17% -$80.2K 0.01% 143
2021
Q4
$442K Buy
7,086
+171
+2% +$10K 0.02% 169
2021
Q3
$412K Buy
+6,915
New +$455K 0.02% 164
2021
Q1
$350K Buy
+5,540
New +$345K 0.03% 168

Other funds holding BMY

E Fund Management's BMY Position: Q1 2026 in Review

E Fund Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 12,904 shares worth $783K. The stake represents 0.02% of the portfolio and ranks #206 among its holdings. This is a return to the name: E Fund Management previously reported a position in BMY as recently as Q2 2025.

E Fund Management first reported a position in BMY in Q1 2021 and has held it in 18 quarters since. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • E Fund Management held 12,904 shares of Bristol-Myers Squibb worth $783K as of Q1 2026.
  • Bristol-Myers Squibb was a new E Fund Management position in Q1 2026.
  • Bristol-Myers Squibb made up 0.02% of E Fund Management's portfolio in Q1 2026, its #206 holding.
  • E Fund Management first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 18 quarters since.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on E Fund Management's 13F filing for Q1 2026, filed 13 Apr 2026.